Viatris (VTRS) Accounts Payables (2019 - 2026)

Viatris' (VTRS) quarterly Accounts Payables came in at $1.7 billion in Q1 2026, down 12.02% year-on-year from $2.0 billion in Q1 2025, and little changed quarter-over-quarter from $1.8 billion in Q4 2025.

Viatris (VTRS) Accounts Payables (2019 - 2026) Analysis & Trends

Viatris' Accounts Payables history runs 8 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

  • On a quarterly basis, Accounts Payables fell 12.02% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 12.02% decrease from a year earlier, with the FY2025 full-year figure at $1.8 billion, down 5.37% from the prior year.
  • Accounts Payables was little changed at $1.7 billion in Q1 2026 per VTRS's latest filing, from $1.8 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.2 billion in Q1 2024 and bottomed at $1.3 billion in Q3 2022.
  • The 5-year median for Accounts Payables is $1.9 billion (2024), against an average of $1.8 billion.
  • Across the five-year window, Accounts Payables decreased 26.61% in 2022 and surged 51.78% in 2023, its largest moves.
  • Year by year, Accounts Payables stood at $1.8 billion in 2022, then advanced by 9.71% to $1.9 billion in 2023, then decreased by 4.36% to $1.9 billion in 2024, then retreated by 5.37% to $1.8 billion in 2025, then dropped by 0.27% to $1.7 billion in 2026.
  • Per Business Quant, the three latest VTRS Accounts Payables figures stand at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 507.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 1.67 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 58.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.75 Bn
Dec 31, 2025 1.75 Bn
Sep 30, 2025 1.79 Bn
Jun 30, 2025 1.78 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 1.85 Bn
Sep 30, 2024 1.93 Bn
Jun 30, 2024 1.96 Bn
Mar 31, 2024 2.20 Bn
Dec 31, 2023 1.94 Bn
Sep 30, 2023 1.99 Bn
Jun 30, 2023 1.96 Bn
Mar 31, 2023 1.96 Bn
Dec 31, 2022 1.77 Bn
Sep 30, 2022 1.31 Bn
Jun 30, 2022 1.67 Bn
Mar 31, 2022 1.50 Bn
Dec 31, 2021 1.66 Bn
Sep 30, 2021 1.66 Bn
Jun 30, 2021 1.80 Bn